Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Luis C. PenaPresident & CEO | EvommuneEVMN | Open-market sale10b5-1 plan | 06/22 | 06/24 | 7,438 sh | $22.71 | $168,916.98 | −1.2% |
Janice Suzann DrewChief of Dev. Operations | EvommuneEVMN | Open-market sale10b5-1 plan | 06/22 | 06/24 | 20,000 sh | $22.63 | $452,600 | −22.8% |
Jeegar Pravinkumar PatelChief Scientific Officer | EvommuneEVMN | Open-market sale10b5-1 plan | 06/22 | 06/24 | 1,488 sh | $22.50 | $33,480 | −3.1% |
EvommuneEVMN | Open-market sale10b5-1 plan | 06/02 | 06/03 | 6,056 sh2 trades | $20.33avg. | $123,093.76 | −25.6% | |
Luis C. PenaPresident & CEO | EvommuneEVMN | Open-market sale10b5-1 plan | 06/01 | 06/03 | 16,787 sh | $22.74 | $381,736.38 | −2.6% |
Jeegar Pravinkumar PatelChief Scientific Officer | EvommuneEVMN | Open-market sale10b5-1 plan | 06/01 | 06/03 | 16,687 sh | $22.74 | $379,462.38 | −26.4% |
Gregory S. MossChief Business & Legal Officer | EvommuneEVMN | Open-market sale10b5-1 plan | 05/28 | 06/01 | 14,223 sh | $22.83 | $324,711.09 | −18.9% |
Kyle CarverCFO | EvommuneEVMN | Open-market sale10b5-1 plan | 05/28 | 06/01 | 18,175 sh | $22.84 | $415,117 | −23.4% |
Robert Lorne HopfnerDirector | EvommuneEVMN | Open-market buy | 25/12/19 | 25/12/22 | 1,000 sh | $17.35 | $17,350 | +33.0% |
Director | EvommuneEVMN | Open-market buy | 25/11/07 | 25/11/12 | 1,250,000 sh2 trades | $16.00avg. | $20,000,000 | No record |
7 Cooperative Ua Lsp10% Owner | EvommuneEVMN | Open-market buy | 25/11/07 | 25/11/12 | 1,562,500 sh | $16.00 | $25,000,000 | +46.4% |
Weegen Felice Isabel Verduyn-vanDirector | EvommuneEVMN | Open-market buy | 25/11/07 | 25/11/12 | 1,562,500 sh | $16.00 | $25,000,000 | +46.4% |
